For research use only
| Cat No. | ABC-TC0954 |
| Product Type | Human Myoma Cell Lines |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Muscle |
| Product Code | R D; RD-2; RD 2; 130T; 130-T; 130 T; TE-32; TE 32; TE32; TE 32.T; Te 32.T |
Human RD rhabdomyosarcoma cells with MYC, NRAS, TP53 mutations for cancer research, drug testing, and embryonal tumor modeling.
| Product Code | R D; RD-2; RD 2; 130T; 130-T; 130 T; TE-32; TE 32; TE32; TE 32.T; Te 32.T |
| Species | Human |
| Cat.No | ABC-TC0954 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Muscle |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Myoma Cell Lines |
The RD cell line is a classical model for studying rhabdomyosarcoma, a pediatric soft tissue cancer. It has been used to evaluate chemotherapy agents like vincristine and cyclophosphamide and investigate molecular events involved in tumor progression and metastasis. RD cells are also valuable in multistage carcinogenesis studies and drug screening, particularly for exploring anti-cancer compounds and their effects on tumor growth and gene expression.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
